Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (31-40 of 279) with videos related to

Pageof 28
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2023
Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure EvaluationChad E Mire, Benjamin A Satterfield, Thomas W Geisbert
Clinics in Laboratory Medicine|July 4, 2006
Viral hemorrhagic feversAileen M Marty, Peter B Jahrling, Thomas W Geisbert
Journal of Virology|August 11, 2021
Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome SystemCorri B Levine, Chad E Mire, Thomas W Geisbert
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment VirusesMichael A Whitt, Thomas W Geisbert, Chad E Mire
Journal of Bioterrorism & Biodefense|January 31, 2012
Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus InfectionsAndrea Marzi, Heinz Feldmann, Thomas W Geisbert, et al.
Expert Opinion on Drug Discovery|October 2, 2018
Small animal models of filovirus disease: recent advances and future directionsRobert W Cross, Karla A Fenton, Thomas W Geisbert
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2023
Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus InfectionBenjamin A Satterfield, Chad E Mire, Thomas W Geisbert
Expert Review of Vaccines|April 15, 2016
Ebola virus vaccines - reality or fiction?Chad E Mire, Thomas W Geisbert, Heinz Feldmann, et al.
The Journal of Infectious Diseases|December 6, 2007
Epitopes required for antibody-dependent enhancement of Ebola virus infectionAyato Takada, Hideki Ebihara, Heinz Feldmann, et al.
Nature Reviews. Drug Discovery|January 30, 2018
Post-exposure treatments for Ebola and Marburg virus infectionsRobert W Cross, Chad E Mire, Heinz Feldmann, et al.
Pageof 28

Showing results (31-40 of 279) with videos related to

Sort By:
Pageof 28
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2023
Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure EvaluationChad E Mire, Benjamin A Satterfield, Thomas W Geisbert
Clinics in Laboratory Medicine|July 4, 2006
Viral hemorrhagic feversAileen M Marty, Peter B Jahrling, Thomas W Geisbert
Journal of Virology|August 11, 2021
Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome SystemCorri B Levine, Chad E Mire, Thomas W Geisbert
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment VirusesMichael A Whitt, Thomas W Geisbert, Chad E Mire
Journal of Bioterrorism & Biodefense|January 31, 2012
Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus InfectionsAndrea Marzi, Heinz Feldmann, Thomas W Geisbert, et al.
Expert Opinion on Drug Discovery|October 2, 2018
Small animal models of filovirus disease: recent advances and future directionsRobert W Cross, Karla A Fenton, Thomas W Geisbert
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2023
Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus InfectionBenjamin A Satterfield, Chad E Mire, Thomas W Geisbert
Expert Review of Vaccines|April 15, 2016
Ebola virus vaccines - reality or fiction?Chad E Mire, Thomas W Geisbert, Heinz Feldmann, et al.
The Journal of Infectious Diseases|December 6, 2007
Epitopes required for antibody-dependent enhancement of Ebola virus infectionAyato Takada, Hideki Ebihara, Heinz Feldmann, et al.
Nature Reviews. Drug Discovery|January 30, 2018
Post-exposure treatments for Ebola and Marburg virus infectionsRobert W Cross, Chad E Mire, Heinz Feldmann, et al.
Pageof 28